Ethics in the digital workplace
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The Danish pharma group Novo Nordisk has announced to cut 400 positions in its research and development (R&D) services in Denmark and China. Novo Nordisk, which is the world’s biggest insulin maker, has decided to refocuses its R&D efforts on 'transformational biological and technological innovation'. Therefore, administrative staff, laboratory technicians and scientists working in the R&D services will be laid off in Denmark and China. But Novo Nordisk will also hire specialists in areas such as computational biology, stem cells and new disease areas (but the number of job creations is not known). The company has decided to reorganise the structure of its R&D organisation, creating internally four research units based in Denmark, the US and the UK. These units will operate as satellites of the company’s central R&D function. Novo Nordisk employs more than 43,000 people worldwide.
Eurofound (2018), Novo Nordisk, Internal restructuring in World, factsheet number 95497, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/95497.